Can extracellular vesicles be considered as a potential frontier in the treatment of intervertebral disc disease? DOI Creative Commons
S.Y. Zhu, Junlin Wang,

Moran Suo

и другие.

Ageing Research Reviews, Год журнала: 2023, Номер 92, С. 102094 - 102094

Опубликована: Окт. 18, 2023

As a global public health problem, low back pain (LBP) caused by intervertebral disc degeneration (IDD) seriously affects patients' quality of life. In addition, the prevalence IDD tends to be younger, which brings huge burden individuals and society economically. Current treatments do not delay or reverse progression IDD. The emergence biologic therapies has brought new hope for treatment Among them, extracellular vesicles (EVs), as nanoscale bioactive substances that mediate cellular communication, have now produced many surprising results in research This article reviews mechanisms roles EVs delaying describes prospects challenges EVs.

Язык: Английский

Polydopamine Nanoparticles Targeting Ferroptosis Mitigate Intervertebral Disc Degeneration Via Reactive Oxygen Species Depletion, Iron Ions Chelation, and GPX4 Ubiquitination Suppression DOI Creative Commons
Xiao Yang, Yan Chen,

Jiadong Guo

и другие.

Advanced Science, Год журнала: 2023, Номер 10(13)

Опубликована: Март 23, 2023

Intervertebral disc degeneration (IVDD)-induced lower back pain (LBP) is a common problem worldwide. The underlying mechanism partially accredited to ferroptosis, based on sequencing analyses of IVDD patients from the gene expression omnibus (GEO) databases. In this study, it shown that polydopamine nanoparticles (PDA NPs) inhibit oxidative stress-induced ferroptosis in nucleus pulposus (NP) cells vitro. PDA NPs scavenge reactive oxygen species (ROS), chelate Fe

Язык: Английский

Процитировано

82

Apoptotic Bodies Derived from Fibroblast‐Like Cells in Subcutaneous Connective Tissue Inhibit Ferroptosis in Ischaemic Flaps via the miR‐339‐5p/KEAP1/Nrf2 Axis DOI Creative Commons

Gaoxiang Yu,

Yijie Chen, Ningning Yang

и другие.

Advanced Science, Год журнала: 2024, Номер 11(24)

Опубликована: Апрель 19, 2024

Abstract Preventing and treating avascular necrosis at the distal end of flaps are critical to surgery success, but current treatments not ideal. A recent study shows that apoptotic bodies (ABs) generated near site apoptosis can be taken up promote cell proliferation. The reveals ABs derived from fibroblast‐like cells in subcutaneous connective tissue (FSCT cells) skin promoted ischaemic flap survival. It is also found inhibited death oxidative stress M1‐to‐M2 polarization macrophages. Transcriptome sequencing protein level testing demonstrated survival endothelial macrophages by inhibiting ferroptosis via KEAP1‐Nrf2 axis. Furthermore, microRNA (miR) data vitro vivo experiments KEAP1 delivering miR‐339‐5p exert therapeutic effects. In conclusion, FSCT cell‐derived ferroptosis, macrophage transition miR‐339‐5p/KEAP1/Nrf2 axis These results provide a potential strategy administering ABs.

Язык: Английский

Процитировано

16

The mechanisms and functions of IL-1β in intervertebral disc degeneration DOI Creative Commons
Hongtao Li, Xiaoqiang Wang, Hongyu Pan

и другие.

Experimental Gerontology, Год журнала: 2023, Номер 177, С. 112181 - 112181

Опубликована: Апрель 24, 2023

Intervertebral disc degeneration (IDD) is the leading cause of low back pain (LBP) and disability in elderly, imposing significant public health economic burden worldwide. Meanwhile, pathological mechanisms IDD remain complicated, treatment strategy to reverse primarily due unclear specific lack particular effective targets. Interleukin-1β (IL-1β), one most important members IL-1 family, can induce solid pro-inflammatory activity by stimulating secretion various mediators considered key mediator. However, recent years, IL-1β be able regulate IVD cell death many ways, such as apoptosis, pyroptosis, ferroptosis, so on. At same time, numerous studies on inhibitors suggest that inhibition may a promising biological therapy for IDD. Many have been investigated through pathogenic mechanisms, including inhibiting inflammatory processes, regulating ECM degradation, more. Therefore, anti-IL-1β effect alleviating degeneration. This article mainly reviews functions investigates advances biotherapeutic approach

Язык: Английский

Процитировано

30

The role of ferroptosis in intervertebral disc degeneration DOI Creative Commons

Chun‐Yang Fan,

Genglei Chu, Zilin Yu

и другие.

Frontiers in Cell and Developmental Biology, Год журнала: 2023, Номер 11

Опубликована: Июль 27, 2023

Nucleus pulposus, annulus fibrosus, and cartilage endplate constitute an avascular intervertebral disc (IVD), which is crucial for spinal joint mobility. As one of the most widespread health issues worldwide, degeneration (IVDD) recognized as a key contributor to back neck discomfort. A number degenerative disorders have strong correlation with ferroptosis, recently identified novel regulated cell death (RCD) characterized by iron-dependent mechanism buildup lipid reactive oxygen species (ROS). There growing interest in part ferroptosis plays IVDD pathophysiology. Inhibiting has been shown control development. Several studies demonstrated that TBHP-induced oxidative stress models, changes marker protein levels increased peroxidation lead cells, subsequently aggravates IVDD. Similarly, significantly relieved use inhibitors. The purpose this review was threefold: 1) discuss occurrence IVDD; 2) understand its role pathophysiology; 3) investigate feasibility prospect treatment.

Язык: Английский

Процитировано

26

MicroRNA-targeting nanomedicines for the treatment of intervertebral disc degeneration DOI Creative Commons
Hussein H. Genedy, P. Humbert,

Bilel Laoulaou

и другие.

Advanced Drug Delivery Reviews, Год журнала: 2024, Номер 207, С. 115214 - 115214

Опубликована: Фев. 22, 2024

Язык: Английский

Процитировано

13

Mesenchymal stem cells and ferroptosis: Clinical opportunities and challenges DOI Creative Commons

Mengling Cui,

Fukun Chen,

Lishi Shao

и другие.

Heliyon, Год журнала: 2024, Номер 10(3), С. e25251 - e25251

Опубликована: Фев. 1, 2024

This review discusses recent experimental and clinical findings related to ferroptosis, with a focus on the role of MSCs. Therapeutic efficacy current applications MSC-based ferroptosis therapies are also discussed.

Язык: Английский

Процитировано

8

Nrf2 activation: a key mechanism in stem cell exosomes-mediated therapies DOI Creative Commons
Zeinab Vahidinia,

Abolfazl Azami Tameh,

Shirin Barati

и другие.

Cellular & Molecular Biology Letters, Год журнала: 2024, Номер 29(1)

Опубликована: Март 2, 2024

Abstract Exosomes are nano-sized membrane extracellular vesicles which can be released from various types of cells. originating inflammatory or injured cells have detrimental effects on recipient cells, while exosomes derived stem not only facilitate the repair and regeneration damaged tissues but also inhibit inflammation provide protective against diseases, suggesting they may serve as an alternative strategy transplantation. a fundamental role in communication between through transfer proteins, bioactive lipids nucleic acids (like miRNAs mRNAs) This significantly impacts both physiological pathological functions Nuclear factor erythroid 2–related 2 (Nrf2), transcription factor, is able to mitigate damage caused by oxidative stress signaling pathways. The positive resulting activation Nrf2 pathway different disorders been documented literature. Studies confirmed that could act effective agonists. However, limited studies explored therapeutic cell-derived exosomes. review provides comprehensive overview existing knowledge concerning pathways impact exerted cell some common diseases. Graphical

Язык: Английский

Процитировано

8

Regulation of the Nrf2/HO-1 axis by mesenchymal stem cells-derived extracellular vesicles: implications for disease treatment DOI Creative Commons

Hua Su,

Zhongan Wang,

Lidan Zhou

и другие.

Frontiers in Cell and Developmental Biology, Год журнала: 2024, Номер 12

Опубликована: Июнь 10, 2024

This comprehensive review inspects the therapeutic potential of mesenchymal stem cell-derived extracellular vesicles (MSC-EVs) across multiple organ systems. Examining their impact on integumentary, respiratory, cardiovascular, urinary, and skeletal systems, study highlights versatility MSC-EVs in addressing diverse medical conditions. Key pathways, such as Nrf2/HO-1, consistently emerge central mediators antioxidative anti-inflammatory effects. From expediting diabetic wound healing to mitigating oxidative stress-induced skin injuries, alleviating acute lung even offering solutions for conditions like myocardial infarction renal ischemia-reperfusion injury, demonstrate promising efficacy. Their adaptability different administration routes identifying specific factors opens avenues innovative regenerative strategies. positions candidates future clinical applications, providing a overview medicine.

Язык: Английский

Процитировано

8

Innovating intervertebral disc degeneration therapy: Harnessing the power of extracellular vesicles DOI Creative Commons
Shanfeng Chen,

Yiming Dou,

Yiming Zhang

и другие.

Journal of Orthopaedic Translation, Год журнала: 2025, Номер 50, С. 44 - 55

Опубликована: Янв. 1, 2025

Язык: Английский

Процитировано

1

Application of mesenchymal stem cell-derived exosomes from different sources in intervertebral disc degeneration DOI Creative Commons

Yuanliang Xia,

Ruohan Yang,

Yulin Hou

и другие.

Frontiers in Bioengineering and Biotechnology, Год журнала: 2022, Номер 10

Опубликована: Окт. 7, 2022

Intervertebral disc degeneration (IVDD) is a main cause of lower back pain, leading to psychological and economic burdens patients. Physical therapy only delays pain in patients but cannot eliminate the IVDD. Surgery required when patient tolerate or has severe neurological symptoms. Although surgical resection IVD decompression laminae eliminates diseased segment, it damages adjacent normal IVD. There also risk re-protrusion after removal. Cell played crucial role development regenerative medicine. transplantation promotes regeneration degenerative tissue. However, owing lack vascular structure IVD, sufficient nutrients be provided for transplanted mesenchymal stem cells (MSCs). In addition, dead release harmful substances that aggravate Extracellular vesicles (EVs) have been extensively studied as an emerging therapeutic approach. EVs generated by paracrine MSCs retain potential serve carriers deliver their contents target regulate cell activity. Owing double-layered membrane structure, low immunogenicity no immune rejection. Therefore, are considered modality they limited mass production loading rates. this review, advantages introduced, application MSC-EVs IVDD discussed. The current limitations future applications described.

Язык: Английский

Процитировано

36